{
    "eid": "2-s2.0-85111050451",
    "title": "Immunogenicity studies of plant-produced sars-cov-2 receptor binding domain-based subunit vaccine candidate with different adjuvant formulations",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Adjuvant",
        "COVID-19",
        "Plant-based vaccine",
        "Receptor-binding domain",
        "SARS-CoV-2",
        "Sub-unit vaccine"
    ],
    "authors": [
        "Konlavat Siriwattananon",
        "Suwimon Manopwisedjaroen",
        "Balamurugan Shanmugaraj",
        "Eakachai Prompetchara",
        "Chutitorn Ketloy",
        "Supranee Buranapraditkun",
        "Kittipan Tharakhet",
        "Papatsara Kaewpang",
        "Kiat Ruxrungtham",
        "Arunee Thitithanyanont",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 14,
    "ref-count": 102,
    "ref-list": [
        "Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19)",
        "Characteristics of SARS-CoV-2 and COVID-19",
        "Emergence of novel Coronavirus 2019-nCoV: Need for rapid vaccine and biologics development",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
        "Coronavirus vaccine development: From SARS and MERS to COVID-19",
        "SARS-CoV-2 vaccines: Status report",
        "Immunological considerations for COVID-19 vaccine strategies",
        "Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates",
        "Potential adjuvants for the development of a SARS-CoV-2 vaccine based on T experimental results from similar coronaviruses",
        "Development of vaccines for SARS-CoV-2",
        "COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies",
        "Recent advances in the production of recombinant subunit vaccines in Pichia pastoris",
        "Recombinant protein subunit vaccine synthesis in microbes: A role for yeast?",
        "Playing catch-up with Escherichia coli: Using yeast to increase success rates in recombinant protein production experiments",
        "Recent advances in subunit vaccine carriers",
        "COVID-19 vaccine: A comprehensive status report",
        "Selection of adjuvants for vaccines targeting specific pathogens",
        "Modes of action for mucosal vaccine adjuvants",
        "Vaccine adjuvants: From 1920 to 2015 and beyond",
        "COVID-19: Coronavirus vaccine development updates",
        "Adjuvants for animal vaccines",
        "New adjuvants for human vaccines",
        "Mechanisms of stimulation of the immune response by aluminum adjuvants",
        "Correlates of adjuvanticity: A review on adjuvants in licensed vaccines",
        "Mode of action of adjuvants: Implications for vaccine safety and design",
        "The mechanism of action of MF59\u2014An innately attractive adjuvant formulation",
        "From discovery to licensure, the adjuvant system story",
        "Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant",
        "Vaccine adjuvants\u2014Current status and prospects on controlled release adjuvancity",
        "Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine",
        "AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity",
        "Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge",
        "TLR3 ligand Poly (I:C) exerts distinct actions in synovial fibroblasts when delivered by extracellular vesicles",
        "Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells",
        "TLR3 agonists and proinflamma-tory antitumor activities",
        "Vaccine adjuvant uses of poly-IC and derivatives",
        "New age adjuvants and delivery systems for subunit vaccines",
        "Current advancements and potential strategies in the development of MERS-CoV vaccines",
        "Vaccine adjuvants: Current state and future trends",
        "Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus",
        "NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge",
        "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice",
        "Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant",
        "CoVaccine HT\u2122 adjuvant is superior to Freund\u2019s adjuvants in eliciting antibodies against the endogenous alarmin HMGB1",
        "A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets",
        "A statistically defined endpoint titer determination method for immunoassays",
        "Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays",
        "Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2",
        "A review on SARS-CoV-2 virology, pathophysiology, animal Models, and anti-Viral interventions",
        "Genetic and pathogenic characterization of SARS-CoV-2: A review",
        "SARS-CoV-2: Structure, biology, and structure-based therapeutics development",
        "COVID-19 pathophysiology: A review",
        "RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response",
        "A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity",
        "Coronavirus disease 2019 (COVID-19): Current status and future perspectives",
        "Immunogenicity of a DNA vaccine candidate for COVID-19",
        "Next-generation vaccine platforms for COVID-19",
        "Production of virus-like particles for vaccines",
        "Key roles of adjuvants in modern vaccines",
        "Improving vaccine performance with adjuvants",
        "Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients",
        "A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults",
        "Enhancing immunogenicity of a 3\u2032aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana",
        "Plant molecular farming: A viable platform for recombinant biopharmaceutical production",
        "Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro",
        "Plant-made oral vaccines against human infectious diseases\u2014Are we there yet?",
        "Plant-based vaccines against viruses",
        "Plant-based vaccines for animals and humans: Recent advances in technology and clinical trials",
        "Plant molecular pharming for the treatment of chronic and infectious diseases",
        "Plant molecular farming for the production of valuable proteins\u2014Critical evaluation of achievements and future challenges",
        "Potential applications of plant biotechnology against SARS-CoV-2",
        "Plant-based vaccines as a global vaccination approach: Current perspectives",
        "Pilot production of SARS-CoV-2 related proteins in plants: A proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities",
        "Towards an understanding of the adjuvant action of aluminium",
        "Immune adjuvant effect of molecularly-defined Toll-like receptor ligands",
        "The immunobiology of aluminium adjuvants: How do they really work?",
        "Immunology and efficacy of MF59-adjuvanted vaccines",
        "The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4",
        "Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A",
        "Adjuvants enhancing cross-presentation by dendritic cells: The key to more effective vaccines?",
        "Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity",
        "Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant",
        "Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN",
        "Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo",
        "Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective Immunity against Influenza",
        "Human IgG subclasses: In vitro neutralization of and in vivo protection against West Nile virus",
        "Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice",
        "Virally induced modulation of murine IgG antibody subclasses",
        "Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection",
        "Biologic functions of the IFN-\u03b3 receptors",
        "Interferon-gamma: Biology and role in pathogenesis",
        "Cellular responses to interferon-gamma",
        "Role of interferons in the development of diagnostics, vaccines, and therapy for tuberculosis",
        "Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice",
        "A direct role for IFN-gamma in regulation of Th1 cell development"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "117011815",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117011815",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Baiya Phytopharm Co., Ltd.",
        "Chulalongkorn University"
    ]
}